Inhibition of the autocrine IL-6–JAK2–STAT3–calprotectin axis as targeted therapy for HR<sup>−</sup>/HER2<sup>+</sup>breast cancersRuth Rodríguez‐Barrueco, José M. Silva, Kevin Kalinsky et al.|Genes & Development|2015Cited by 121
Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivorsDawn L. Hershman, Katherine D. Crew, Heather Greenlee et al.|Breast Cancer Research and Treatment|2013Cited by 117
Presurgical Trial of Metformin in Overweight and Obese Patients with Newly Diagnosed Breast CancerKevin Kalinsky, Dawn L. Hershman, Katherine D. Crew et al.|Cancer Investigation|2014Cited by 80
¡Cocinar Para Su Salud!: Randomized Controlled Trial of a Culturally Based Dietary Intervention among Hispanic Breast Cancer SurvivorsHeather Greenlee, Dawn L. Hershman, Ann Ogden Gaffney et al.|Journal of the Academy of Nutrition and Dietetics|2015Cited by 73
Metformin and erlotinib synergize to inhibit basal breast cancerYing-Ka Ingar Lau, Matthew Maurer|Oncotarget|2014Cited by 56